These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21864418)

  • 1. Inhibition of advanced glycation end-product formation on eye lens protein by rutin.
    Muthenna P; Akileshwari C; Saraswat M; Bhanuprakash Reddy G
    Br J Nutr; 2012 Apr; 107(7):941-9. PubMed ID: 21864418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications.
    Saraswat M; Reddy PY; Muthenna P; Reddy GB
    Br J Nutr; 2009 Jun; 101(11):1714-21. PubMed ID: 18986599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products.
    Pashikanti S; de Alba DR; Boissonneault GA; Cervantes-Laurean D
    Free Radic Biol Med; 2010 Mar; 48(5):656-63. PubMed ID: 19969069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
    Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
    Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
    Ahmad MS; Pischetsrieder M; Ahmed N
    Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.
    Lunceford N; Gugliucci A
    Fitoterapia; 2005 Jul; 76(5):419-27. PubMed ID: 15894431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites.
    Cervantes-Laurean D; Schramm DD; Jacobson EL; Halaweish I; Bruckner GG; Boissonneault GA
    J Nutr Biochem; 2006 Aug; 17(8):531-40. PubMed ID: 16443355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products.
    Saxena P; Saxena AK; Cui XL; Obrenovich M; Gudipaty K; Monnier VM
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1473-81. PubMed ID: 10798665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted benzenediol Schiff bases as promising new anti-glycation agents.
    Choudhary MI; Abbas G; Ali S; Shuja S; Khalid N; Khan KM; Atta-ur-Rahman ; Basha FZ
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):98-103. PubMed ID: 20583858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design.
    Khalifah RG; Chen Y; Wassenberg JJ
    Ann N Y Acad Sci; 2005 Jun; 1043():793-806. PubMed ID: 16037307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA; Khalifah RG; Hudson BG
    Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of glycation to cataract formation in diabetes.
    Stevens A
    J Am Optom Assoc; 1998 Aug; 69(8):519-30. PubMed ID: 9747048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl- L -carnitine decreases glycation of lens proteins: in vitro studies.
    Swamy-Mruthinti S; Carter AL
    Exp Eye Res; 1999 Jul; 69(1):109-15. PubMed ID: 10375455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of putative anti-cataract agents in the prevention of protein glycation.
    Stevens A
    J Am Optom Assoc; 1995 Dec; 66(12):744-9. PubMed ID: 8557952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay of diabetic cataract in rats by the antiglycating potential of cumin through modulation of alpha-crystallin chaperone activity.
    Kumar PA; Reddy PY; Srinivas PN; Reddy GB
    J Nutr Biochem; 2009 Jul; 20(7):553-62. PubMed ID: 18789666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
    Khalifah RG; Baynes JW; Hudson BG
    Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin as a finer substitute to aminoguanidine in the inhibition of glycation products.
    Ashraf JM; Shahab U; Tabrez S; Lee EJ; Choi I; Ahmad S
    Int J Biol Macromol; 2015; 77():188-92. PubMed ID: 25799884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathological implications of protein glycation.
    Brownlee M
    Clin Invest Med; 1995 Aug; 18(4):275-81. PubMed ID: 8549013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
    Miyata T; Yamamoto M; Izuhara Y
    Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.